Study identifier:D5980R00123
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Clinical and dEmographic chaRacteristics of patients with frequent COPD Exacerbations and evaluation of therapeutic approaches in treatment in RussiA
Chronic obstructive pulmonary disease (COPD)
N/A
No
-
All
2000
Observational
18 Years - 100 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jun 2025 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|